Life Sciences

BLOG ENTRY

March Economic Snapshot: Research and Development in the Life Sciences

 |  NYCEDC
At present, NYC may not be living up to its full potential in terms of biotech capital and development infrastructure but there is significant potential. Our March Economic Snapshot reveals opportunities for growth and ways that NYC can transform itself into the next locus of life science innovation.

Economic Data

March 2015 Economic Snapshot

Research and development in the Life Sciences in NYC as well as our regular summary of the city's economy.

BLOG ENTRY

NYC's Growing Life Sciences Ecosystem

 |  NYCEDC
Home to top pharmaceutical companies and the most prestigious centers of basic science - not to mention the largest healthcare system in the country - NYC is uniquely positioned to lead in the life sciences. Here are all the ways we are nurturing the sector right here in the five boroughs.

BLOG ENTRY

NYC: A Leader In Life Sciences

 |  NYCEDC
NYC's presence in the life sciences is growing. In 2013, NYC earned $1.4 billion in NIH funding. Read this and more in our Life Sciences report.

BLOG ENTRY

New York City's $100 Million Investment In Life Sciences

 |  NYCEDC
Three major initiatives will bolster NYC's life sciences industry: the City of New York Early-Stage Life Sciences Funding Initiative, Mount Sinai Institute of Technology, and Harlem Biospace.

PRESS RELEASE

Deputy Mayor Steel And NYCEDC Announce Two New Initiatives to Dramatically Grow City's Life Sciences Sector

Deputy Mayor for Economic Development Robert K. Steel and New York City Economic Development Corporation President Kyle Kimball today announced two major initiatives to help New York City grow into a preeminent capital for life sciences innovation in the world.

Programs for Entrepreneurs /  Life Sciences

NYC Early-Stage Life Sciences Funding Initiative

Last Updated

Launched with anchor participation from NYCEDC, Celgene, GE Ventures, and Eli Lilly, the City of New York Early-Stage Life Sciences Funding Initiative seeks to launch 15 to 20 breakthrough ventures by 2020.